Travere Announces Proposed Convertible Senior Notes Offering to Refinance 2029 Convertible Notes

Key Takeaway: Travere Therapeutics has announced a proposed offering of convertible senior notes aimed at refinancing its 2029 convertible notes. This move is part of the company's financial strategy to manage its debt obligations effectively. Further details regarding the terms and conditions of the offering are expected to be released soon.